DTC Effect On Patient Benefit, Compliance Needs More Study – FDA’s Temple

The effect of direct-to-consumer advertising on patient behavior needs to be further studied, FDA Center for Drug Evaluation & Research Office of Medical Policy Director Robert Temple, MD, suggested